Medical News

RSS

China PharmaHub, University of California enter license agreement for stem cell universal donor blood product

China PharmaHub Corp., a biopharmaceutical acquisition and development company, today announced that it has signed a exclusive worldwide license agreement with the University of California, for worldwide rights to develop, commercialize and market a universal donor blood product derived from embryonic stem cells developed by UCSD Associate Professor of Medicine and Pediatrics Dr. Ewa Carrier.

21 Mar 2011

ViroPharma launches online community for teens and adults with hereditary angioedema

ViroPharma Incorporated today announced the launch of "HAE and Me," an online community that unites teens and adults with hereditary angioedema (HAE) through shared experiences to help them better manage their disease.

21 Mar 2011

ADDF awards ADispell 170,750 grant to develop drugs against Alzheimer's Disease

The Alzheimer's Drug Discovery Foundation (ADDF) announced that it has awarded a grant of $170,750 to ADispell Inc. to develop small molecule drugs designed to halt the progression of cognition loss that occurs with Alzheimer's Disease.

21 Mar 2011

Gingrich predicts undoing of health law in early 2013

The actual repeal, according to the former House speaker and possible GOP presidential hopeful, will not take place until after the 2012 election is over. However, he adds that efforts to defund it will continue — and are likely to be successful — before that.

21 Mar 2011

Researcher reverses ageing process in bee's brain

Norwegian researcher Gro Amdam has succeeded in reversing the ageing process in the bee brain - findings which she believes may bring hope to people with dementia.

21 Mar 2011

Premier healthcare alliance named one of World's Most Ethical Companies for 2011

The Premier healthcare alliance has been named one of the Ethisphere Institute's 2011 World's Most Ethical Companies for the fourth year in a row. Ethisphere selected Premier from a record number of applicants across the globe.

21 Mar 2011

Study identifies gene linked to higher risk of multiple sclerosis in children

Canadians have one of the highest rates of Multiple Sclerosis (MS) in the world with approximately 1,000 new cases diagnosed each year. Primarily striking in adulthood, physicians and researchers with the Canadian Pediatric Demyelinating Diseases Network (CPDDN), a multi-institutional and multidisciplinary group, have found that MS is being increasingly diagnosed in children.

21 Mar 2011

Exchanges, waivers continue to draw scrutiny

The New York Times reports on how the health law's waivers have fueled GOP criticism, offering opponents what they say is "more evidence" of the measure's flaws. Meanwhile, CQ HealthBeat reports on concerns surrounding the health exchanges.

21 Mar 2011

March of Dimes awards Healthy Babies Healthy Business Seal of Approval to The Children's Hospital in Denver

The March of Dimes today announced it has awarded its first-ever Healthy Babies Healthy Business Seal of Approval, to The Children's Hospital in Denver. Children's becomes the first organization in Colorado - and the nation - to earn this new certification.

21 Mar 2011

Svelte Medical completes 6 month follow up in initial Acrobat angioplasty system clinical trial

Svelte™ Medical Systems, Inc. is pleased to announce that it has completed 6 month follow up in its initial clinical trial with the Svelte Acrobat angioplasty system.

21 Mar 2011

Study unravels molecular mechanism of biomolecule RNA that plays dynamic regulatory role in protein selection

If a big bunch of your brain cells suddenly went rogue and decided to become fat cells, it could cloud your decision-making capacity a bit. Fortunately, early in an organism's development, cells make firm and more-or-less permanent decisions about whether they will live their lives as, say, skin cells, brain cells or, well, fat cells.

21 Mar 2011

NIH spending at risk in budget battle

When House Republicans took power in 1995 determined to cut spending in a battle that shut down the U.S. government, then-House Speaker Newt Gingrich was persuaded to spare the National Institutes of Health.

21 Mar 2011

Abbott receives CE-Mark for new qualitative PCR-based HIV-1 test

Abbott (NYSE: ABT) announced today that it has received CE-Mark for a new qualitative PCR-based HIV-1 test that produces highly accurate results from dried blood spot and plasma specimens. The new assay is a long-awaited diagnostic tool for health officials in African nations and other resource-limited areas to detect HIV-1 infected infants at early stages and begin treatment when success is more likely.

21 Mar 2011

Sarsia Seed provides follow-up funding for APIM Therapeutics

APIM Therapeutics AS, an early-stage Norwegian therapeutic company, is pursuing a novel drug approach with the ability to potentiate the action of a wide range of chemotherapeutic drugs currently used to treat several types of cancer.

21 Mar 2011

SLEH treats irregular heartbeat with novel minimally invasive cold cryoballoon technology

A physician affiliated with Texas Heart® Institute (THI) at St. Luke's Episcopal Hospital (SLEH) is the first in Houston and among the first in the nation to treat patients for an irregular heartbeat with a new, minimally invasive cryoballoon technology that uses cold rather than heat to interrupt faulty electrical circuits in the heart.

21 Mar 2011

AOBO board announces $20 million share buyback program

American Oriental Bioengineering, Inc., a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter ("OTC") products, announced at its 2010 earnings conference call, held on March 15, 2011, that its board of directors authorized a share buyback program for the repurchase of up to $20 million of the Company's outstanding common stock over the next two years.

21 Mar 2011

Intravenous Phenoxodiol-cisplatin combination well tolerated in platinum resistant ovarian cancer

Marshall Edwards, Inc., an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced today the publication of results from a Phase II clinical trial of intravenous Phenoxodiol in combination with cisplatin in women with platinum-resistant ovarian cancer.

21 Mar 2011

Roundup: Kan., Calif. budget cuts; Texas NICU costs; Katrina trial; Medco CalPERS contract 'dumped'

This list of programs cut in the California state budget includes a 10 percent reduction in what the state pays for Medi-Cal patients at all long-term care facilities $172.3 million and a 10 percent reduction in what the state pays to physicians who see people on Medi-Cal.

21 Mar 2011

Curemark reaches targeted enrollment in CM-AT Phase III clinical trials for autism

Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced that the company has completed its targeted enrollment of Phase III clinical trials for CM-AT, its autism treatment.

21 Mar 2011

CardioFocus secures $5M in debt financing from Silicon Valley Bank

CardioFocus, a venture capital-backed medical device company developing technology to treat cardiac disorders, has secured $5M in debt financing from Silicon Valley Bank, financial partner to technology and life science companies of all sizes worldwide. CardioFocus will use the new financing to initiate its pivotal trial in the United States and to expand the commercialization of its products in Europe.

21 Mar 2011

Medical News

China PharmaHub, University of California enter license agreement for stem cell universal donor blood product

ViroPharma launches online community for teens and adults with hereditary angioedema

ADDF awards ADispell 170,750 grant to develop drugs against Alzheimer's Disease

Gingrich predicts undoing of health law in early 2013

Researcher reverses ageing process in bee's brain

Premier healthcare alliance named one of World's Most Ethical Companies for 2011

Study identifies gene linked to higher risk of multiple sclerosis in children

Exchanges, waivers continue to draw scrutiny

March of Dimes awards Healthy Babies Healthy Business Seal of Approval to The Children's Hospital in Denver

Svelte Medical completes 6 month follow up in initial Acrobat angioplasty system clinical trial

Study unravels molecular mechanism of biomolecule RNA that plays dynamic regulatory role in protein selection

NIH spending at risk in budget battle

Abbott receives CE-Mark for new qualitative PCR-based HIV-1 test

Sarsia Seed provides follow-up funding for APIM Therapeutics

SLEH treats irregular heartbeat with novel minimally invasive cold cryoballoon technology

AOBO board announces $20 million share buyback program

Intravenous Phenoxodiol-cisplatin combination well tolerated in platinum resistant ovarian cancer

Roundup: Kan., Calif. budget cuts; Texas NICU costs; Katrina trial; Medco CalPERS contract 'dumped'

Curemark reaches targeted enrollment in CM-AT Phase III clinical trials for autism

CardioFocus secures $5M in debt financing from Silicon Valley Bank

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News